GlassScriptPhysician profile
Larry R Glazerman
NPI 1356397574
$31,492.22
in general payments reported to CMS, 2019-2025
7 companies · $7,213 in 2025
The $7,213 reported for 2025 was more than what 98% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,119 · 2020: $13K · 2021: $3,500 · 2022: $2,164 · 2023: $731 · 2024: $3,010 · 2025: $7,213.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $9,351 · Food and Beverage: $812 · Travel and Lodging: $758 · Education: $32.27.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $9,350.95 |
| Food and Beverage | $812.40 |
| Travel and Lodging | $758.41 |
| Education | $32.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hologic Sales and Service, LLC | $15,182.50 | 2020-2021 | |
| Exeltis, USA INC. | $11,403.91 | 2020-2025 | Slynd |
| Pfizer INC. | $2,732.15 | 2022-2023 | |
| Coopersurgical, INC. | $2,019.46 | 2019 | |
| Gen-Probe, INC. | $99.82 | 2019 | |
| Novo Nordisk INC | $32.27 | 2023 | Wegovy |
| Cytyc Surgical Products, LLC | $22.11 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Larry Glazerman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.